Haoxi Health Technology Limited (HAO) Stock Price & Analysis
Haoxi Health Technology Limited (HAO) is trading at USD 2.09, down 2.57% today, as of October 23, 2026 at 15:37 UTC (US market open; quotes may be delayed), according to Nexqual market data.
HAO last closed at USD 2.14; today's session has ranged USD 2.02–2.13 on volume of 2,942 shares. Market capitalization is $763,372, with a 52-week range of USD 1.95–4,352 (NCM). Source: Nexqual, retrieved October 23, 2026 at 16:21 UTC.
Also available as compact Markdown for AI agents: nexqual.com/HAO.md
Key facts (HAO)
- Insider open-market purchases, last ~7 months: 1 Form 4 filing, $720K; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: None.
- Total return with dividends: 1Y -99.9% vs S&P 500 +14.7%; 5Y -100.0% vs S&P 500 +77.5%.
Insider purchases (SEC Form 4, open-market, last ~7 months) (HAO)
1 purchase, $720K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-05-19 | Fan Zhen | CEO & Chairman | 40,000,000 | $720K | 0.02 | Too little history (no open-market trades in 2023–2025) |
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (HAO)
Consensus None.
Total return (dividends reinvested) (HAO)
| 1Y (from 2025-10-23) | 5Y (from 2024-01-22) | |
|---|---|---|
| Total return | -99.9% | -100.0% |
| S&P 500 (SPY) | +14.7% | +77.5% |
| Per year | -99.9% | -95.9% |
| Volatility (annualized) | 319.9% | 331.9% |
| Max drawdown | -100.0% (Jan 2026→Oct 2026) | -100.0% (Apr 2024→Oct 2026) |
HAO suppliers, customers and competitors (named in its 20-F)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Supplier | Tencent | “The operating entity engages suppliers which are mainstream media platforms or their key agents, such as Tencent and Toutiao.” |
| Customer | ByteDance | “The operating entity is materially dependent on media platforms operated by ByteDance to acquire user traffic and place ads for its advertiser customers.” |
| Customer | Network Technology | “Suzhou 190 Network Technology Co., Ltd., Chengdu Mei'erbei Technology Co., Ltd., and Shanghai Xukang Network Technology Co., LTD were, respectively, our top customers during fiscal years ended June 30, 2026, 2025, and 2024, with Suzhou 190 Network Technology Co., Ltd. accounting for 10.68% of our total revenues for the fiscal year ended June 30, 2026, Shanghai Xukang Network Technology Co., LTD accounting for 6.87…” |
Quoted from the company's 20-F filed Sep 30, 2026.
HAO analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter | — | — | — | $0 | — |
| Next quarter (ends Jun 2024) | — | — | — | $0 | — |
| Current fiscal year (ends Jun 2024) | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |
Key Statistics (as of October 23, 2026 at 16:21 UTC)
| Price | USD 2.09 |
|---|---|
| Change | ▼ 2.57% (down) |
| Previous Close | USD 2.14 |
| Open | USD 2.02 |
| Day Range | USD 2.02 – 2.13 |
| 52-Week Range | USD 1.95 – 4,352 |
| Volume | 2,942 shares |
| Market Cap | $763,372 |
| Exchange | NCM |
Technical Analysis (HAO)
Nexqual's technical model rates HAO "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of October 23, 2026 at 16:21 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 33.25 (neutral) |
| vs SMA50 | Below (USD 2.89) |
| MACD | -0.69 (negative) |
Analyst Ratings (HAO)
Wall Street analysts rate HAO "None", per Nexqual as of October 23, 2026 at 16:21 UTC.
| Consensus Rating | None |
|---|
Earnings (HAO)
Source: Nexqual, October 23, 2026 at 16:21 UTC.
Financials & Fundamentals (HAO)
| Total Revenue | $54.83M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +137.30% |
| Gross Margin | +1.15% |
| Operating Margin | -11.81% |
| Profit Margin | -17.39% |
| ROE | -54.13% |
| Debt / Equity | 0.09 |
| Current Ratio | 4.53 |
| Total Cash | $10.93M |
| Total Debt | $1.61M |
Source: Nexqual, October 23, 2026 at 16:21 UTC.
Financial Health Score (HAO)
Nexqual rates Haoxi Health Technology Limited's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 16:21 UTC.
| Growth | Strong — Revenue +137% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Strong — $11M cash vs $2M debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$3M (TTM) |
| Efficiency | Critical — ROE -54%, ROA -23.6% |
Ownership (HAO)
| Insider Ownership | +0.01% |
|---|---|
| Institutional Ownership | +0.49% |
| Shares Outstanding | 350,232 |
| Float | 621,572 |
| Short % of Float | +7.02% |
Source: Nexqual, October 23, 2026 at 16:21 UTC.
Leadership (HAO)
Haoxi Health Technology Limited is led by Zhen Fan, Chairman & CEO, per Nexqual as of October 23, 2026 at 16:21 UTC.
| Chairman & CEO | Zhen Fan |
|---|---|
| Founder, COO & Director | Lei Xu |
| Chief Financial Officer | Dongxue Li |
Major Backers & Investors (HAO)
Notable institutional backers of Haoxi Health Technology Limited include Marex Group Ltd., according to Nexqual as of October 23, 2026 at 16:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Marex Group Ltd. | 0.32% |
Source: Nexqual, October 23, 2026 at 16:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TJGC | TJGC Group Limited | USD 31.89 | ▲ 0% |
| PERI | Perion Network Ltd | USD 8.68 | ▼ 0.8% |
| ADV | Advantage Solutions Inc. | USD 29.61 | ▼ 2.41% |
| NEXN | Nexxen International Ltd. | USD 8.9 | ▼ 1.66% |
| EVC | Entravision Communications Corp | USD 6.17 | ▼ 1.52% |
| CRTO | Criteo S.A. | USD 14.84 | ▼ 0.24% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 16:21 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt